Costimulation by CD48 and B7-1 induces immunity against poorly immunogenic tumors.
about
Molecular cloning and biological characterization of NK cell activation-inducing ligand, a counterstructure for CD48Therapeutic vaccination with tumor cells that engage CD137.Immunological ignorance of an E7-encoded cytolytic T-lymphocyte epitope in transgenic mice expressing the E7 and E6 oncogenes of human papillomavirus type 16.Use of combinatorial peptide libraries to construct functional mimics of tumor epitopes recognized by MHC class I-restricted cytolytic T lymphocytesDistinct role of antigen-specific T helper type 1 (Th1) and Th2 cells in tumor eradication in vivo.Antigenic cancer cells grow progressively in immune hosts without evidence for T cell exhaustion or systemic anergyCD28-independent induction of T helper cells and immunoglobulin class switches requires costimulation by the heat-stable antigen.Melanoma cells transfected to express CD83 induce antitumor immunity that can be increased by also engaging CD137.Treatment of lymphoma with adoptively transferred T cells.Regulatory properties of statins and rho gtpases prenylation inhibitiors to stimulate melanoma immunogenicity and promote anti-melanoma immune response.Synergistic antitumor effect by coexpression of chemokine CCL21/SLC and costimulatory molecule LIGHT.Chimeric receptors with 4-1BB signaling capacity provoke potent cytotoxicity against acute lymphoblastic leukemia.Gene therapy for cancer using single-chain Fv fragments specific for 4-1BB.Identification of genes associated with dedifferentiation of hepatocellular carcinoma with expression profiling analysis.Administration of agonistic anti‐4–1 BB monoclonal antibody inhibits melanoma metastasis via IFN‐γ production
P2860
Q28137748-DF02E3A8-CAD2-4713-A5B2-1DBCB6817E2BQ35071688-89B80545-C0E5-4E80-83B6-54449F7EE7CFQ35883954-F8028C55-128B-4017-99DE-F203FDA3CC27Q36367022-19E3D885-AFB0-43C5-A38B-936B65A0E0E3Q36375248-1711C4E2-5E7A-45E4-9FCD-330D803130F9Q36380365-7D04E960-726F-4185-928C-5AD0EFAA9673Q36400564-D98F351A-188A-4877-8C66-A2BA20D52A2CQ37415753-E19002B5-88CF-4C99-B83A-0F426917754FQ37419728-FFA6D76F-2ED9-4197-BCFD-BE1880E784F9Q38951511-BC73E724-4F85-4851-8B23-3633582557DEQ40582098-228338AD-98B5-470C-8C8A-AFDFD571B0DFQ40590332-6B123A90-974E-48F7-A4C9-7A0F60AD8FBFQ45884692-0C448E52-51B8-40D2-92AC-DD9478FF035AQ54949817-C204DEFD-451C-453B-86D6-B081B6A3991DQ58187506-753DF5F9-5FC8-4AD9-B5CE-71FB50DDB74E
P2860
Costimulation by CD48 and B7-1 induces immunity against poorly immunogenic tumors.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年学术文章
@wuu
1996年学术文章
@zh-cn
1996年学术文章
@zh-hans
1996年学术文章
@zh-my
1996年学术文章
@zh-sg
1996年學術文章
@yue
1996年學術文章
@zh
1996年學術文章
@zh-hant
name
Costimulation by CD48 and B7-1 induces immunity against poorly immunogenic tumors.
@ast
Costimulation by CD48 and B7-1 induces immunity against poorly immunogenic tumors.
@en
type
label
Costimulation by CD48 and B7-1 induces immunity against poorly immunogenic tumors.
@ast
Costimulation by CD48 and B7-1 induces immunity against poorly immunogenic tumors.
@en
prefLabel
Costimulation by CD48 and B7-1 induces immunity against poorly immunogenic tumors.
@ast
Costimulation by CD48 and B7-1 induces immunity against poorly immunogenic tumors.
@en
P2093
P2860
P356
P1476
Costimulation by CD48 and B7-1 induces immunity against poorly immunogenic tumors.
@en
P2093
P2860
P304
P356
10.1084/JEM.183.2.639
P407
P577
1996-02-01T00:00:00Z